Therapeutic Efficacy of Ozone Injection into the Knee for the Osteoarthritis Patient along with Oral Celecoxib and Glucosamine.

about

Therapeutic Efficacy of Ozone Injection into the Knee for the Osteoarthritis Patient along with Oral Celecoxib and Glucosamine.

Item

http://www.wikidata.org/entity/Q47137980

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@en

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@nl

type

Item

label

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@en

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@nl

prefLabel

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@en

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@nl

P1476

Therapeutic Efficacy of Ozone ...... ral Celecoxib and Glucosamine.

@en

P2093

Li Beiping

http://www.w3.org/2001/XMLSchema#string

Xu Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?

Crystalline glucosamine sulfate in the management of knee osteoarthritis: efficacy, safety, and pharmacokinetic properties

Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis

Knee osteoarthritis related pain: a narrative review of diagnosis and treatment.

Can we identify patients with high risk of osteoarthritis progression who will respond to treatment? A focus on epidemiology and phenotype of osteoarthritis.

Biomechanical considerations in the pathogenesis of osteoarthritis of the knee.

Ozone as Janus: this controversial gas can be either toxic or medically useful.

Ozone exposure initiates a sequential signaling cascade in airways involving interleukin-1beta release, nerve growth factor secretion, and substance P upregulation

Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis

The sources of pain in knee osteoarthritis.

P304

UC01-UC03

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7860/JCDR/2017/26065.10533

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29207809

http://www.w3.org/2001/XMLSchema#string

P932

5713831

http://www.w3.org/2001/XMLSchema#string